Prognosis
Moderna Lifts Vaccine Output Outlook 20% to at Least 600 Million
- Company adds staff to reach goal of as many as 1 billion doses
- Change comes as U.S. considers smaller doses to boost supply
A healthcare worker prepares to administer the Moderna Inc. Covid-19 vaccine at a hospital in Valley Stream, New York, on Dec. 21, 2020.
Photographer: Eduardo Munoz/Reuters/Bloomberg
This article is for subscribers only.
Moderna Inc. said it will make at least 600 million doses of its Covid-19 vaccine in 2021, with a goal of finishing the year with as many as 1 billion doses produced. The shares rose.
The announcement increased the bottom end of the company’s production forecast by 100 million doses. Moderna is “continuing to invest and add staff” to produce the two-shot vaccine, according to a statement by the Cambridge, Massachusetts biotech company on Monday.